연구동향 분석

Genomic Correlates of Unfavorable Outcome in Locally Advanced Cervical Cancer Treated with Neoadjuvant Chemoradiation

Yuchun Wei Chuqing Wei Liang Chen Ning Liu Qiuxiang Ou Jiani C. Yin Jiaohui Pang Zhenhao Fang Xue Wu Xiaonan Wang Dianbin Mu Yang Shao Jinming Yu Shuanghu Yuan 2022년

논문상세정보
인용/피인용
' Genomic Correlates of Unfavorable Outcome in Locally Advanced Cervical Cancer Treated with Neoadjuvant Chemoradiation' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • Pathologic response
  • disease-free survival
  • dnadamagerepair
  • neoadjuvant therapy
  • uterine cervical neoplasms
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
153 0

0.0%

' Genomic Correlates of Unfavorable Outcome in Locally Advanced Cervical Cancer Treated with Neoadjuvant Chemoradiation' 의 참고문헌

  • p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis
  • VarScan 2 : somatic mutation and copy number alteration discovery in cancer by exome sequencing
    Koboldt DC [2012]
  • Trimmomatic: a flexible trimmer for Illumina sequence data
  • The PI3K pathway in human disease
    Fruman DA [2017]
  • The Cancer Genome Atlas(TCGA) : an immeasurable source of knowledge
    Tomczak K [2015]
  • Role of KEAP1/NRF2 and TP53 mutations in lung squamous cell carcinoma development and radiation resistance
    Jeong Y [2017]
  • Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium
    Pecorelli S [2009]
  • Results from neoadjuvant chemotherapy followed by surgery compared to chemoradiation for stage Ib2-IIb cervical cancer, EORTC 55994
    Kenter G [2019]
  • ReactomePA : an R/Bioconductor package for reactome pathway analysis and visualization
    Yu G [2016]
  • Progressive 3q amplification consistently targets SOX2 in preinvasive squamous lung cancer
    McCaughan F [2010]
  • Pathological response after neoadjuvant chemotherapy in resectable non-small-cell lung cancers : proposal for the use of major pathological response as a surrogate endpoint
    Hellmann MD [2014]
  • Pan-cancer landscape of homologous recombination deficiency
    Nguyen L [2020]
  • PIK3CA gene amplification in Japanese non-small cell lung cancer
    Kawano O [2007]
  • PIK3CA amplification is predictive of poor prognosis in Tunisian patients with nasopharyngeal carcinoma
    Fendri A [2009]
  • PIK3CA amplification is associated with poor prognosis among patients with curatively resected esophageal squamous cell carcinoma
    Kim HS [2016]
  • Neoadjuvant chemotherapy followed by radical surgery versus concomitant chemotherapy and radiotherapy in patients with stage IB2, IIA, or IIB squamous cervical cancer : a randomized controlled trial
    Gupta S [2018]
  • Neoadjuvant brachytherapy and chemotherapy followed by radical surgery for stage IB2 and IIA cervical cancer : a retrospective comparison with chemoirradiation
    Ma Y [2018]
  • Mechanisms underlying the activation of TERT transcription and telomerase activity in human cancer : old actors and new players
    Yuan X [2019]
  • Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth
    Ohta T [2008]
  • Investigating novel resistance mechanisms to third-generation EGFR tyrosine kinase inhibitor osimertinib in non-small cell lung cancer patients
    Yang Z [2018]
  • Human papillomavirus type 16 E6 activates TERT gene transcription through induction of c-Myc and release of USF-mediated repression
    McMurray HR [2003]
  • Histopathologic response criteria predict survival of patients with resected lung cancer after neoadjuvant chemotherapy
    Pataer A [2012]
  • High frequency of pathogenic germline variants within homologous recombination repair in patients with advanced cancer
    Bertelsen B [2019]
  • Global cancer statistics 2018 : GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
    Bray , F. , [2018]
  • Genome-wide association study identifies four SNPs associated with response to platinum-based neoadjuvant chemotherapy for cervical cancer
    Li X [2017]
  • Genetic susceptibility in cervical cancer : From bench to bedside
    Bahrami A [2018]
  • Familial risks, early-onset breast cancer, and BRCA1 and BRCA2 germline mutations
    Dite GS [2003]
  • FACTERA : a practical method for the discovery of genomic rearrangements at breakpoint resolution
    Newman AM [2014]
  • Evidence of NTRK1 fusion as resistance mechanism to EGFR TKI in EGFR+ NSCLC : results from a large-scale survey of NTRK1 fusions in Chinese patients with lung cancer
    Xia H [2020]
  • Epidemiologic classification of human papillomavirus types associated with cervical cancer
    Munoz N [2003]
  • Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix
  • Comprehensive genomic profiling identifies novel genetic predictors of response to anti-PD-(L)1 therapies in non-small cell lung cancer
    Fang W [2019]
  • Circulating tumor DNA mutation profiling by targeted next generation sequencing provides guidance for personalized treatments in multiple cancer types
    Shu Y [2017]
  • Changes in prevalence and clinical characteristics of cervical cancer in the People’s Republic of China : a study of 10, 012 cases from a nationwide working group
    Li S [2013]
  • Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Marth C [2017]
  • Cervical cancer : a global health crisis
    Small W Jr [2017]
  • Cancer statistics in China, 2015
    Chen, W. [2016]
  • Cancer risks associated with germline PALB2 pathogenic variants : an international study of 524 families
    Yang X [2020]
  • An evaluation of SOX2 and hTERC gene amplifications as screening markers in oral and oropharyngeal squamous cell carcinomas
  • AACR Project GENIE : Powering Precision Medicine through an International Consortium
  • 3q26-29 Amplification in head and neck squamous cell carcinoma : a review of established and prospective oncogenes
    Davidson MA [2017]
  • 3q26 amplifications in cervical squamous carcinomas